These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 20352149)

  • 21. [Hydrotalcite in the treatment of reflux esophagitis: a multicenter clinical study].
    Hydrotalcid Multicenter Clinical Cooperative Group
    Zhonghua Nei Ke Za Zhi; 2001 Dec; 40(12):819-22. PubMed ID: 16206671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double-blind clinical, endoscopic and histological comparison of hydrotalcite/dimethicone suspension and magnesium hydroxide/aluminum hydroxide suspension in the treatment of symptomatic gastritis.
    Cobden I; McMahon MJ; Dixon MF; Axon AT
    Pharmatherapeutica; 1981; 2(9):607-12. PubMed ID: 7267678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do obesity and diabetes increase the frequency and risk of bile reflux gastritis post-cholecystectomy?
    Othman AAA; Dewedar AAZ; ElSadek HM; AbdelAziz HR; AdelRahman AAF
    Pol Przegl Chir; 2022 Jan; 94(5):1-8. PubMed ID: 36169584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy of hydrotalcite compared with OTC famotidine in the on-demand treatment of gastroesophageal reflux disease: a non-inferiority trial.
    Konturek JW; Beneke M; Koppermann R; Petersen-Braun M; Weingärtner U
    Med Sci Monit; 2007 Jan; 13(1):CR44-9. PubMed ID: 17179910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dealing with postcholecystectomy syndrome.
    Comstock D
    Nursing; 2008 Apr; 38(4):17-9. PubMed ID: 18360221
    [No Abstract]   [Full Text] [Related]  

  • 26. Mechanism for hydrotalcite decomposition: a controlled rate thermal analysis study.
    Vágvölgyi V; Palmer SJ; Kristóf J; Frost RL; Horváth E
    J Colloid Interface Sci; 2008 Feb; 318(2):302-8. PubMed ID: 17991479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk for gastric cancer after cholecystectomy.
    Fall K; Ye W; Nyrén O
    Am J Gastroenterol; 2007 Jun; 102(6):1180-4. PubMed ID: 17355416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endoscopical and histological features in bile reflux gastritis.
    Vere CC; Cazacu S; Comănescu V; Mogoantă L; Rogoveanu I; Ciurea T
    Rom J Morphol Embryol; 2005; 46(4):269-74. PubMed ID: 16688361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review article: physiologic and clinical effects of proton pump inhibitors on non-acidic and acidic gastro-oesophageal reflux.
    Miner PB
    Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():25-32. PubMed ID: 16483267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review article: relationship between the metabolism and efficacy of proton pump inhibitors--focus on rabeprazole.
    Horn J
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 6():11-9. PubMed ID: 15496214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of muscarinic receptor signaling by bile acids: physiological and medical implications.
    Raufman JP; Cheng K; Zimniak P
    Dig Dis Sci; 2003 Aug; 48(8):1431-44. PubMed ID: 12924634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-cholecystectomy alkaline reactive gastritis: a randomized trial comparing sucralfate versus rabeprazole or no treatment.
    Santarelli L; Gabrielli M; Candelli M; Cremonini F; Nista EC; Cammarota G; Gasbarrini G; Gasbarrini A
    Eur J Gastroenterol Hepatol; 2003 Sep; 15(9):975-9. PubMed ID: 12923369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Barrett's esophagus: what is the poison - alkaline, biliary or acidic reflux?
    Gutschow CA; Schröder W; Hölscher AH
    Dis Esophagus; 2002; 15(1):5-9. PubMed ID: 12060036
    [No Abstract]   [Full Text] [Related]  

  • 34. Gastro-oesophageal reflux and duodenogastric reflux before and after eradication in Helicobacter pylori gastritis.
    Manifold DK; Anggiansah A; Rowe I; Sanderson JD; Chinyama CN; Owen WJ
    Eur J Gastroenterol Hepatol; 2001 May; 13(5):535-9. PubMed ID: 11396533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased acid and bile reflux in Barrett's esophagus compared to reflux esophagitis, and effect of proton pump inhibitor therapy.
    Menges M; Müller M; Zeitz M
    Am J Gastroenterol; 2001 Feb; 96(2):331-7. PubMed ID: 11232672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The extent of duodenogastric reflux in gastro-oesophageal reflux disease.
    Marshall RE; Anggiansah A; Owen WA; Manifold DK; Owen WJ
    Eur J Gastroenterol Hepatol; 2001 Jan; 13(1):5-10. PubMed ID: 11204810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Duodenogastric reflux is associated with antral metaplastic gastritis.
    Nakamura M; Haruma K; Kamada T; Mihara M; Yoshihara M; Imagawa M; Kajiyama G
    Gastrointest Endosc; 2001 Jan; 53(1):53-9. PubMed ID: 11154489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytoprotective effect of rabeprazole against ethanol-induced gastric mucosal damage: possible involvement of nitric oxide.
    Watanabe T; Higuchi K; Tominaga K; Fujiwara Y; Arakawa T
    Drugs Exp Clin Res; 2000; 26(2):41-5. PubMed ID: 10894554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Leeds Dyspepsia Questionnaire: a valid tool for measuring the presence and severity of dyspepsia.
    Moayyedi P; Duffett S; Braunholtz D; Mason S; Richards ID; Dowell AC; Axon AT
    Aliment Pharmacol Ther; 1998 Dec; 12(12):1257-62. PubMed ID: 9882035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bile reflux in benign and malignant Barrett's esophagus: effect of medical acid suppression and nissen fundoplication.
    Stein HJ; Kauer WK; Feussner H; Siewert JR
    J Gastrointest Surg; 1998; 2(4):333-41. PubMed ID: 9841990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.